8-[3-fluoro-4-[2-oxo-3-[2-pyrazol-1-yl-5-(trifluoromethyl)phenyl]propyl]phenoxy]-4H-pyrido[2,3-b]pyrazin-3-one
C26H17F4N5O3 — CID 152816604
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-[3-fluoro-4-[2-oxo-3-[2-pyrazol-1-yl-5-(trifluoromethyl)phenyl]propyl]phenoxy]-4H-pyrido[2,3-b]pyrazin-3-one
8-[3-fluoro-4-[2-oxo-3-[2-pyrazol-1-yl-5-(trifluoromethyl)phenyl]propyl]phenoxy]-4H-pyrido[2,3-b]pyrazin-3-one (PubChem CID 152816604) has the molecular formula C26H17F4N5O3 and a molecular weight of 523.45 g/mol. Its IUPAC name is 8-[3-fluoro-4-[2-oxo-3-[2-pyrazol-1-yl-5-(trifluoromethyl)phenyl]propyl]phenoxy]-4H-pyrido[2,3-b]pyrazin-3-one.
Molecular Properties
| Compound Name | 8-[3-fluoro-4-[2-oxo-3-[2-pyrazol-1-yl-5-(trifluoromethyl)phenyl]propyl]phenoxy]-4H-pyrido[2,3-b]pyrazin-3-one |
|---|---|
| PubChem CID | 152816604 |
| Molecular Formula | C26H17F4N5O3 |
| Molecular Weight | 523.45 g/mol |
| Exact Mass | 523.13 |
| IUPAC Name | 8-[3-fluoro-4-[2-oxo-3-[2-pyrazol-1-yl-5-(trifluoromethyl)phenyl]propyl]phenoxy]-4H-pyrido[2,3-b]pyrazin-3-one |
| SMILES | O=C(Cc1ccc(Oc2ccnc3[nH]c(=O)cnc23)cc1F)Cc1cc(C(F)(F)F)ccc1-n1cccn1 |
| InChI | InChI=1S/C26H17F4N5O3/c27-20-13-19(38-22-6-8-31-25-24(22)32-14-23(37)34-25)4-2-15(20)11-18(36)12-16-10-17(26(28,29)30)3-5-21(16)35-9-1-7-33-35/h1-10,13-14H,11-12H2,(H,31,34,37) |
| InChIKey | SSMTUSDOTLUYLR-UHFFFAOYSA-N |
| XLogP | 4.81 |
| TPSA | 102.76 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 523.45 |
| LogP ≤ 5 | 4.81 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 152816604 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.